Neogen (NEOG) Non Operating Income (2010 - 2026)
Neogen (NEOG) posted quarterly Non Operating Income of -$15.2 million for Q2 2026, up 24.0% year-over-year from -$12.3 million in Q2 2025, and up 10.59% quarter-over-quarter from -$17.0 million in Q1 2026.
Neogen (NEOG) Non Operating Income (2010 - 2026) Analysis & Trends
Neogen's Non Operating Income history runs 17 years deep, the most recent figure standing at -$15.2 million for Q2 2026.
- In Q2 2026, Non Operating Income rose 24.0% year-over-year to -$15.2 million; the TTM figure through May 2026 stood at $12.7 million (up 117.64% YoY), while the FY2026 annual figure was $12.6 million, up 117.48% from the prior year.
- Non Operating Income for Q2 2026 stood at -$15.2 million, up from -$17.0 million in the prior quarter.
- The five-year high for Non Operating Income was $59.9 million in Q3 2025, with the low at -$26.4 million in Q4 2022.
- The 5-year median for Non Operating Income is -$17.2 million (2023), against an average of -$10.6 million.
- The sharpest annual moves came in 2022 and 2023: Non Operating Income surged 628.93% in 2022, then sank 6845.86% in 2023.
- Neogen's Non Operating Income stood at -$26.4 million in 2022, then surged by 31.11% to -$18.2 million in 2023, then fell by 4.81% to -$19.1 million in 2024, then increased by 21.48% to -$15.0 million in 2025, then retreated by 1.42% to -$15.2 million in 2026.
- Business Quant data shows NEOG's Non Operating Income at -$15.2 million in Q2 2026, -$17.0 million in Q1 2026, and -$15.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | 46.00 Mn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | 6.60 Mn |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | - |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | -12.30 Mn |
| 10 | Neogen | 2.58 Bn | 2.39 Bn | 107.80 Mn | -15.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -15.20 Mn |
| Feb 28, 2026 | -17.00 Mn |
| Nov 30, 2025 | -14.99 Mn |
| Aug 31, 2025 | 59.90 Mn |
| May 31, 2025 | -20.01 Mn |
| Feb 28, 2025 | -15.10 Mn |
| Nov 30, 2024 | -19.09 Mn |
| Aug 31, 2024 | -17.87 Mn |
| May 31, 2024 | -19.44 Mn |
| Feb 29, 2024 | -17.85 Mn |
| Nov 30, 2023 | -18.21 Mn |
| Aug 31, 2023 | -17.47 Mn |
| May 31, 2023 | -15.78 Mn |
| Feb 28, 2023 | -17.94 Mn |
| Nov 30, 2022 | -26.44 Mn |
| Aug 31, 2022 | 597,000.00 |
| May 31, 2022 | 632,000.00 |
| Feb 28, 2022 | 266,000.00 |
| Nov 30, 2021 | 459,000.00 |
| Aug 31, 2021 | -18,000.00 |